IKARIA INC has a total of 30 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2007. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and medical technology are PFIZER HEALTH AB, ASPEN GLOBAL INCORPORATED and IVAX CORP.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 10 | |
#2 | United States | 8 | |
#3 | EPO (European Patent Office) | 4 | |
#4 | Mexico | 3 | |
#5 | Canada | 2 | |
#6 | Brazil | 1 | |
#7 | Republic of Korea | 1 | |
#8 | New Zealand | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Medical technology | |
#4 | Biotechnology | |
#5 | Foods and drinks | |
#6 | Mechanical elements |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Acyclic or carbocyclic compounds | |
#4 | Syringes | |
#5 | Heterocyclic compounds | |
#6 | Microorganisms | |
#7 | Organic chemistry methods | |
#8 | Compressed gas holders | |
#9 | Enzymes | |
#10 | Diagnosis and surgery |
# | Name | Total Patents |
---|---|---|
#1 | Szabo Csaba | 18 |
#2 | Tomaselli Kevin J | 12 |
#3 | Deckwerth Thomas L | 12 |
#4 | Wintner Edward | 10 |
#5 | Hill Paul A | 10 |
#6 | Wintner Edward Aurel | 5 |
#7 | Ruan Fuqiang | 4 |
#8 | Su Chienmin | 3 |
#9 | Klaus John | 2 |
#10 | Insko Michael A | 2 |
Publication | Filing date | Title |
---|---|---|
US2018066298A1 | Functionally modified polypeptides and radiobiosynthesis | |
US2010183748A1 | Methods for Treating or Preventing Radiocontrast Agent Induced Kidney Injury | |
EP2349236A2 | Compositions and methods for treating or preventing hypoxic or ischemic injury | |
US2008199541A1 | Liquid chalcogenide compositions and methods of manufacturing and using the same | |
US2010143503A1 | Combinations of nitric oxide and sulfide and methods of use and manufacture thereof | |
WO2008070741A1 | Compositions and methods for enhancing survival and reducing injury under ischemic or hypoxic conditions | |
NZ575671A | Liquid chalcogenide compositions and methods of manufacturing and using the same | |
US2007265223A1 | Compositions and methods of enhancing survivability and reducing injury of cells, tissues, organs, and organisms under hypoxic or ischemic conditions |